Accelerated aging syndromes, are they relevant to normal human aging?

Aging

Volumn 3, Issue 9, 2011, Pages 889-895

  Dreesen, Oliver ^a   Stewart, Colin L ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

Aging; DNA damage; Hutchinson Gilford Progeria; Lef1; Telomeres; Werner syndrome; Wnt signaling

Indexed keywords

EXODEOXYRIBONUCLEASE; LAMIN A; RECQ HELICASE; WRN PROTEIN, HUMAN;

ADULT; AGING; ANIMAL; ARTICLE; CHILD; DISEASE MODEL; DNA DAMAGE; GENETICS; GENOMIC INSTABILITY; HUMAN; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGERIA; WERNER SYNDROME;

AGING; ANIMALS; CHILD; DISEASE MODELS, ANIMAL; DNA DAMAGE; EXODEOXYRIBONUCLEASES; GENOMIC INSTABILITY; HUMANS; LAMIN TYPE A; MICE; MUTATION; PROGERIA; RECQ HELICASES; WERNER SYNDROME; YOUNG ADULT;

EID: 84856646656     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100383     Document Type: Article

References (63)

1. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol. 2002; 20: 682-688.
2. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010; 464: 520-528.
3. Austad SN. Comparative aging and life histories in mammals. Exp Gerontol. 1997; 32: 23-38.
4. de Lange T. How telomeres solve the end-protection problem. Science. 2009; 326: 948-952.
5. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet. 2009; 10: 45-61.
6. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009; 361: 2353-2365.
7. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, and Schellenberg GD. Positional cloning of the Werner's syndrome gene. Science. 1996; 272: 258-262.
8. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, and Levy N. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003; 300: 2055.
9. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, and Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson- Gilford progeria syndrome. Nature. 2003; 423: 293-298.
10. Crabbe L, Verdun RE, Haggblom CI, and Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science. 2004; 306: 1951-1953.
11. Opresko PL, Cheng WH, and Bohr VA. Junction of RecQ helicase biochemistry and human disease. J Biol Chem. 2004; 279: 18099-18102.
12. Crabbe L, Jauch A, Naeger CM, Holtgreve-Grez H, and Karlseder J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci U S A. 2007; 104: 2205-2210.
13. Wyllie FS, Jones CJ, Skinner JW, Haughton MF, Wallis C, Wynford-Thomas D, Faragher RG, and Kipling D. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet. 2000; 24: 16-17.
14. Burke B, Stewart CL. The laminopathies: the functional architecture of the nucleus and its contribution to disease. Annu Rev Genomics Hum Genet. 2006; 7: 369-405.
15. Yang SH, Andres DA, Spielmann HP, Young SG, and Fong LG. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J Clin Invest. 2008; 118: 3291-3300.
16. Liu Y, Rusinol A, Sinensky M, Wang Y, and Zou Y. DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci. 2006; 119: 4644-4649.
17. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, and Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet. 2004; 41: 304-308.
18. McClintock D, Gordon LB, and Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci U S A. 2006; 103: 2154-2159.
19. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med. 2005; 11: 440-445.
20. Dechat T, Shimi T, Adam SA, Rusinol AE, Andres DA, Spielmann HP, Sinensky MS, and Goldman RD. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci U S A. 2007; 104: 4955-4960.
21. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, and Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992; 89: 10114-10118.
22. Decker ML, Chavez E, Vulto I, and Lansdorp PM. Telomere length in Hutchinson-Gilford progeria syndrome. Mech Ageing Dev. 2009; 130: 377-383.
23. Kudlow BA, Stanfel MN, Burtner CR, Johnston ED, and Kennedy BK. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53. Mol Biol Cell. 2008; 19: 5238-5248.
24. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadinanos J, Lopez-Otin C, Tse HF, Hutchison C, Chen J, Cao Y, Cheah KS, Tryggvason K, and Zhou Z. Genomic instability in laminopathybased premature aging. Nat Med. 2005; 11: 780-785.
25. Musich PR, Zou Y. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A. Aging (Albany NY). 2009; 1: 28-37.
26. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, and Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003; 426: 194-198.
27. Takai H, Smogorzewska A, and de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol. 2003; 13: 1549-1556.
28. Benson EK, Lee SW, and Aaronson SA. Role of progerininduced telomere dysfunction in HGPS premature cellular senescence. J Cell Sci. 2010; 123: 2605-2612.
29. De Vos WH, Houben F, Hoebe RA, Hennekam R, van Engelen B, Manders EM, Ramaekers FC, Broers JL, and Van Oostveldt P. Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins. Biochim Biophys Acta. 2010; 1800: 448-458.
30. Dimitrova N, Chen YC, Spector DL, and de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature. 2008; 456: 524-528.
31. Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, and von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell. 2009; 8: 311-323.
32. Schumacher B, Garinis GA, and Hoeijmakers JH. Age to survive: DNA damage and aging. Trends Genet. 2008; 24: 77-85.
33. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, Oostendorp R, Ahmad A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GT, Meinecke P, Kleijer WJ, Vijg J, Jaspers NG, and Hoeijmakers JH. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006; 444: 1038-1043.
34. Lebel M, Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci U S A. 1998; 95: 13097-13102.
35. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, and Guarente L. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol. 2000; 20: 3286-3291.
36. Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000; 28: 4474-4478.
37. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A. 1995; 92: 4818-4822.
38. Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L, and DePinho RA. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet. 2004; 36: 877-882.
39. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, and Stewart CL. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature. 2003; 423: 298-301.
40. Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, Tryggvason K, Freije JM, and Lopez-Otin C. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature. 2005; 437: 564-568.
41. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, and Lopez-Otin C. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet. 2002; 31: 94-99.
42. Varga R, Eriksson M, Erdos MR, Olive M, Harten I, Kolodgie F, Capell BC, Cheng J, Faddah D, Perkins S, Avallone H, San H, Qu X, Ganesh S, Gordon LB, Virmani R, Wight TN, Nabel EG, and Collins FS. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006; 103: 3250-3255.
43. Bergo MO, Gavino B, Ross J, Schmidt WK, Hong C, Kendall LV, Mohr A, Meta M, Genant H, Jiang Y, Wisner ER, Van Bruggen N, Carano RA, Michaelis S, Griffey SM, and Young SG. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A. 2002; 99: 13049-13054.
44. Yang SH, Meta M, Qiao X, Frost D, Bauch J, Coffinier C, Majumdar S, Bergo MO, Young SG, and Fong LG. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest. 2006; 116: 2115-2121.
45. Hernandez L, Roux KJ, Wong ES, Mounkes LC, Mutalif R, Navasankari R, Rai B, Cool S, Jeong JW, Wang H, Lee HS, Kozlov S, Grunert M, Keeble T, Jones CM, Meta MD, Young SG, Daar IO, Burke B, Perantoni AO, and Stewart CL. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell. 2010; 19: 413-425.
46. Stewart C, Burke B. Teratocarcinoma stem cells and early mouse embryos contain only a single major lamin polypeptide closely resembling lamin B. Cell. 1987; 51: 383-392.
47. Rober RA, Weber K, and Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development. 1989; 105: 365-378.
48. Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y, Tse HF, Stewart CL, and Colman A. A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects. Cell Stem Cell. 2011; 8: 31-45.
49. Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP, Rothman FG, and Sedivy JM. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell. 2004; 3: 235-243.
50. Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008; 10: 452-459.
51. Navarro CL, Cadinanos J, De Sandre-Giovannoli A, Bernard R, Courrier S, Boccaccio I, Boyer A, Kleijer WJ, Wagner A, Giuliano F, Beemer FA, Freije JM, Cau P, Hennekam RC, Lopez-Otin C, Badens C, and Levy N. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet. 2005; 14: 1503-1513.
52. Espada J, Varela I, Flores I, Ugalde AP, Cadinanos J, Pendas AM, Stewart CL, Tryggvason K, Blasco MA, Freije JM, and Lopez- Otin C. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol. 2008; 181: 27-35.
53. Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, Meta M, Bendale P, Gelb MH, Young SG, and Fong LG. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A. 2005; 102: 10291-10296.
54. Sagelius H, Rosengardten Y, Hanif M, Erdos MR, Rozell B, Collins FS, and Eriksson M. Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease. J Cell Sci. 2008; 121: 969-978.
55. Wang Y, Panteleyev AA, Owens DM, Djabali K, Stewart CL, and Worman HJ. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Hum Mol Genet. 2008; 17: 2357-2369.
56. Stehbens WE, Wakefield SJ, Gilbert-Barness E, Olson RE, and Ackerman J. Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol. 1999; 8: 29-39.
57. Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C, Funke B, Smoot L, Gerhard-Herman M, Machan JT, Kutys R, Virmani R, Collins FS, Wight TN, Nabel EG, and Gordon LB. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol. 2010; 30: 2301-2309.
58. Cohen JI, Arnett EN, Kolodny AL, and Roberts WC. Cardiovascular features of the Werner syndrome. Am J Cardiol. 1987; 59: 493-495.
59. Manolagas SC, Almeida M. Gone with the Wnts: betacatenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol. 2007; 21: 2605-2614.
60. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, Alt FW, and DePinho RA. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 2003; 421: 643-648.
61. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL, Panopoulos AD, Suzuki K, Kurian L, Walsh C, Thompson J, Boue S, Fung HL, Sancho-Martinez I, Zhang K, Iii JY, and Belmonte JC. Recapitulation of premature ageing with iPSCs from Hutchinson- Gilford progeria syndrome. Nature. 2011;
62. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J, and Shanahan CM. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation. 2010; 121:2200-2210
63. Rodriguez S, Coppede F, Sagelius H, and Eriksson M. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur J Hum Genet. 2009; 17: 928-937.